arrow
S

Simon Thézenas

Universite de Montpellier
H指数:35
被引数:5,341

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features

三级淋巴结构在三阴性乳腺癌中的预后价值: 肿瘤微环境和临床病理特征的综合分析

2024-12-120
OAAI
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients

三联化疗加西妥昔单抗作为延长RAS野生型转移性结直肠癌患者的一线治疗

2024-08-011
OAAI
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
2021-10-0186
OAAI
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)
2020-12-0112
OAAI
Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure

调强放射治疗肛门癌的长期随访经验: 临床结果,复发模式和失败预测因素

2020-03-0125
OAAI